Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
CRISPR Therapeutics (CRSP) Q3 2026 Earnings
CRSP
10
Aug
Confirmed
Q4 2025
Q1 2026
Q2 2026
Next
-1.37
-1.3
-1.23
-1.16
Details
Expected EPS
-1.196561
Actual EPS
N/A
Surprise EPS
1.2
Surprise Percent
+100%
Description
CRISPR Therapeutics (CRSP) will report earnings of for Q3 2026 on August 10, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login